FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2598114468> ?p ?o ?g. }

• W2598114468 endingPage "205031211770005" @default.
• W2598114468 startingPage "205031211770005" @default.
• W2598114468 abstract "Despite the widespread use of the mouse transverse aortic constriction heart failure model, there are no reports on the characterization of the standard-of-care agent carvedilol in this model.Left ventricular pressure overload was produced in mice by transverse aortic constriction between the innominate and left common carotid arteries. Carvedilol was administered at multiple dose levels (3, 10 and 30 mg/kg/day per os; yielding end-study mean plasma concentrations of 0.002, 0.015 and 0.044 µM, respectively) in a therapeutic design protocol with treatment initiated after the manifestation of left ventricular remodeling at 3 weeks post transverse aortic constriction and continued for 10 weeks.Carvedilol treatment in transverse aortic constriction mice significantly decreased heart rate and left ventricular dP/dt (max) at all dose levels consistent with β-adrenoceptor blockade. The middle dose of carvedilol significantly decreased left ventricular weight, whereas the higher dose decreased total heart, left and right ventricular weight and wet lung weight compared to untreated transverse aortic constriction mice. The higher dose of carvedilol significantly increased cardiac performance as measured by ejection fraction and fractional shortening and decreased left ventricular end systolic volume consistent with the beneficial effect on cardiac function. End-study plasma sST-2 and Gal-3 levels did not differ among sham, transverse aortic constriction control and transverse aortic constriction carvedilol groups. Plasma brain natriuretic peptide concentrations were elevated significantly in transverse aortic constriction control animals (~150%) compared to shams in association with changes in ejection fraction and heart weight and tended to decrease (~30%, p = 0.10-0.12) with the mid- and high-dose carvedilol treatment.A comparison of carvedilol hemodynamic and structural effects in the mouse transverse aortic constriction model versus clinical use indicates a strong agreement in effect profiles preclinical versus clinical, providing important translational validation for this widely used animal model. The present plasma brain natriuretic peptide biomarker findings support the measurement of plasma natriuretic peptides in the mouse transverse aortic constriction model to extend the translational utility of the model." @default.
• W2598114468 created "2017-04-07" @default.
• W2598114468 creator A5020580070 @default.
• W2598114468 creator A5025061802 @default.
• W2598114468 creator A5033985533 @default.
• W2598114468 creator A5040125690 @default.
• W2598114468 creator A5045844294 @default.
• W2598114468 creator A5060038230 @default.
• W2598114468 creator A5060467850 @default.
• W2598114468 creator A5061829952 @default.
• W2598114468 creator A5065320720 @default.
• W2598114468 creator A5066086023 @default.
• W2598114468 creator A5070886756 @default.
• W2598114468 creator A5081623878 @default.
• W2598114468 creator A5083893913 @default.
• W2598114468 creator A5089296878 @default.
• W2598114468 date "2017-03-30" @default.
• W2598114468 modified "2023-10-16" @default.
• W2598114468 title "Effects of carvedilol on structural and functional outcomes and plasma biomarkers in the mouse transverse aortic constriction heart failure model" @default.
• W2598114468 cites W1524057507 @default.
• W2598114468 cites W1598669383 @default.
• W2598114468 cites W1963729186 @default.
• W2598114468 cites W1965407562 @default.
• W2598114468 cites W1979363352 @default.
• W2598114468 cites W1981731045 @default.
• W2598114468 cites W1985849960 @default.
• W2598114468 cites W1989689620 @default.
• W2598114468 cites W1990719112 @default.
• W2598114468 cites W1991720400 @default.
• W2598114468 cites W1993237363 @default.
• W2598114468 cites W2004923834 @default.
• W2598114468 cites W2007688337 @default.
• W2598114468 cites W2008895337 @default.
• W2598114468 cites W2012628515 @default.
• W2598114468 cites W2016532277 @default.
• W2598114468 cites W2025567340 @default.
• W2598114468 cites W2026515462 @default.
• W2598114468 cites W2027712499 @default.
• W2598114468 cites W2032910151 @default.
• W2598114468 cites W2033440372 @default.
• W2598114468 cites W2043586033 @default.
• W2598114468 cites W2043658279 @default.
• W2598114468 cites W2044433156 @default.
• W2598114468 cites W2067571594 @default.
• W2598114468 cites W2075527565 @default.
• W2598114468 cites W2077380630 @default.
• W2598114468 cites W2084656663 @default.
• W2598114468 cites W2085065650 @default.
• W2598114468 cites W2087002521 @default.
• W2598114468 cites W2095014491 @default.
• W2598114468 cites W2096515862 @default.
• W2598114468 cites W2099358413 @default.
• W2598114468 cites W2103365026 @default.
• W2598114468 cites W2119340816 @default.
• W2598114468 cites W2120240698 @default.
• W2598114468 cites W2121177596 @default.
• W2598114468 cites W2121466759 @default.
• W2598114468 cites W2123495845 @default.
• W2598114468 cites W2129967926 @default.
• W2598114468 cites W2141851544 @default.
• W2598114468 cites W2143479093 @default.
• W2598114468 cites W2145015302 @default.
• W2598114468 cites W2146195218 @default.
• W2598114468 cites W21478844 @default.
• W2598114468 cites W2154370947 @default.
• W2598114468 cites W2157097435 @default.
• W2598114468 cites W2157687771 @default.
• W2598114468 cites W2167036398 @default.
• W2598114468 cites W2178738676 @default.
• W2598114468 cites W2180491396 @default.
• W2598114468 cites W2296998040 @default.
• W2598114468 cites W2332030555 @default.
• W2598114468 cites W2339872346 @default.
• W2598114468 cites W2340731691 @default.
• W2598114468 cites W2412724424 @default.
• W2598114468 cites W2427094903 @default.
• W2598114468 cites W2548333061 @default.
• W2598114468 cites W2560842495 @default.
• W2598114468 cites W3023522280 @default.
• W2598114468 cites W4211082352 @default.
• W2598114468 doi "https://doi.org/10.1177/2050312117700057" @default.
• W2598114468 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5406154" @default.
• W2598114468 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28491305" @default.
• W2598114468 hasPublicationYear "2017" @default.
• W2598114468 type Work @default.
• W2598114468 sameAs 2598114468 @default.
• W2598114468 citedByCount "3" @default.
• W2598114468 countsByYear W25981144682018 @default.
• W2598114468 countsByYear W25981144682021 @default.
• W2598114468 crossrefType "journal-article" @default.
• W2598114468 hasAuthorship W2598114468A5020580070 @default.
• W2598114468 hasAuthorship W2598114468A5025061802 @default.
• W2598114468 hasAuthorship W2598114468A5033985533 @default.
• W2598114468 hasAuthorship W2598114468A5040125690 @default.
• W2598114468 hasAuthorship W2598114468A5045844294 @default.
• W2598114468 hasAuthorship W2598114468A5060038230 @default.
• W2598114468 hasAuthorship W2598114468A5060467850 @default.
• W2598114468 hasAuthorship W2598114468A5061829952 @default.

• next